Metraipolis › archive › dc_bcfbad7dface

FDA approves lurbinectedin in combination with atezolizumab for extensive-stage small cell lung cancer — Europe PMC PMID:41254986

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41254986
DOI: 10.1080/2162402x.2025.2584898
License (as archived): solo-consultazione
Archived: 2026-11-08T11:37:10.531Z
SHA-256 of the archived text: 5295863fa96b2907cf1e9b65157459b4ad2fa1d201a1d734215568085dd23705
Stable URL of this page: https://metraipolis.com/documento/dc_bcfbad7dface

How to cite

FDA approves lurbinectedin in combination with atezolizumab for extensive-stage small cell lung cancer — Europe PMC PMID:41254986 — Europe PMC (en), https://europepmc.org/article/MED/41254986 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bcfbad7dface (Metraipolis archive dc_bcfbad7dface, sha256 5295863fa96b2907cf1e9b65157459b4ad2fa1d201a1d734215568085dd23705)

BibTeX

@misc{dcbcfbad7dface,
  title = {FDA approves lurbinectedin in combination with atezolizumab for extensive-stage small cell lung cancer — Europe PMC PMID:41254986},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41254986},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bcfbad7dface; sha256 5295863fa96b2907cf1e9b65157459b4ad2fa1d201a1d734215568085dd23705},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41254986. Agents can read the archived copy with the MCP tool read_document.